BridgeBio Pharma, Inc. Prices Upsized Offering Of $475 Million Convertible Senior Notes

Wednesday, March 4, 2020 1 min read

Key Takeaway: BridgeBio Pharma, Inc. Prices Upsized Offering Of $475 Million Convertible Senior Notes

Full Press Release Details

BridgeBio Pharma, Inc. Prices Upsized Offering Of $475 Million Convertible Senior Notes.